CRVL
CorVel Corporation
CRVL has a slight edge over JPM overall, supported by stronger valuation.
JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
CRVL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
CRVL's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CRVL.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CRVL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 32x | $76.95 | -11% |
| Current | 36x | $86.50 | — |
| Fair | 47x | $111 | +29% |
| Expensive | 59x | $141 | +63% |
Historical ranges are pointers, not guarantees.
CRVL's PE is in its cheap range at 36x.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over CRVL in the historical PE scenario, which offers more potential upside but is not a forecast.
CRVL Forward outlook
There aren't enough analyst estimates for CRVL to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CRVL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.38 | +18% |
| Q2 2026 | $2.25 | +17% |
| Q1 2026 | $2.14 | +17% |
| Q4 2025 | $2.03 | +19% |
| Q3 2025 | $2.02 | +29% |
| Q2 2025 | $1.93 | +29% |
| Q1 2025 | $1.83 | +24% |
| Q4 2024 | $1.70 | +18% |
CRVL has the edge over JPM on earnings, with stronger typical year-over-year growth.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
CRVL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.1M | +11% |
| Q2 2026 | $259.9M | +11% |
| Q1 2026 | $248.5M | +7.4% |
| Q4 2025 | $235.6M | +3.4% |
| Q3 2025 | $239.6M | +6.8% |
| Q2 2025 | $234.7M | +11% |
| Q1 2025 | $231.5M | +12% |
| Q4 2024 | $228M | +13% |
CRVL has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +2.2 points |
| Q2 2026 | 17% | +1.6 points |
| Q1 2026 | 16% | +1.6 points |
| Q4 2025 | 14% | +0.2 points |
| Q3 2025 | 15% | +2.2 points |
| Q2 2025 | 15% | +1.8 points |
| Q1 2025 | 14% | +3.5 points |
| Q4 2024 | 14% | +2.5 points |
CRVL's operating margin was 17% last quarter, up 2.2 points from the same quarter a year ago, near the top of its range since 2019.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over CRVL on profitability, with a higher operating margin.
CRVL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $29.3M | +92% |
| Q2 2026 | $43.1M | +8.9% |
| Q1 2026 | $20.3M | +42% |
| Q4 2025 | $35.2M | +9.5% |
| Q3 2025 | $15.3M | +23% |
| Q2 2025 | $39.5M | +21% |
| Q1 2025 | $14.3M | +174% |
| Q4 2024 | $32.1M | +43% |
CRVL has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CRVL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -238K shares |
| 1 year | -2% | -1M shares |
| 3 years | -2.6% | -1.3M shares |
| 5 years | -7.3% | -4M shares |
| Available history | -8.8% | -4.9M shares |
CRVL has 51M diluted shares, down 2% from a year ago, with $74M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $18.6M |
| Q2 2026 | $22M |
| Q1 2026 | $20.2M |
| Q4 2025 | $13.6M |
| Q3 2025 | $12.8M |
| Q2 2025 | $9.6M |
| Q1 2025 | $9M |
| Q4 2024 | $9.5M |
CRVL spent $74M buying back its own shares over the past year, up 82% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over CRVL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CRVL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
CRVL has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CRVL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 76.6 | Overbought |
| Stochastic | 85.6 | Overbought |
CRVL's weekly RSI is 77 (overbought) and its Stochastic is 86 (overbought).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CRVL PE vs Financial Services Sector
| Metric | CRVL | Sector median | Relative |
|---|---|---|---|
| PE | 36x | 13x | 179% above |
| PE % | 24 | 63 | 39 pts below |
CRVL is trading at 36x earnings, a 179% premium to the Financial Services sector's median of 13x.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over CRVL on valuation relative to its sector.
CRVL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.3 | 7.7% above |
| 20 week MA | $71.3 | 21% above |
| 50 week MA | $64.4 | 34% above |
| 100 week MA | $81.5 | 6.2% above |
| 200 week MA | $80.9 | 7% above |
CRVL has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
CRVL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.8 | $34.7 | +21% |
| 2021 | $34.7 | $66.1 | +90% |
| 2022 | $66.1 | $48.0 | -27% |
| 2023 | $48.0 | $82.4 | +72% |
| 2024 | $82.4 | $113.7 | +38% |
| 2025 | $113.7 | $69.1 | -39% |
| 2026 YTD | $69.1 | $86.5 | +25% |
CRVL has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.